Track topics on Twitter Track topics that are important to you
PLEASANT GROVE, Utah, Aug. 1, 2017 /PRNewswire/ -- doTERRA, the world leader in sourcing, testing, manufacturing and distribution of CPTG® essential oils, today announced the publication of 13 research studies by scientific experts at doTERRA. Each of the comprehensive research studies focuses on one or more essential oil and unveils important information about the efficacy and potency of these essential oils. doTERRA's science team continuously conducts research to remain at the forefront of essential oil science and to ensure Wellness Advocates and consumers receive the highest-quality, therapeutic-grade essential oils in the world.
doTERRA's science team includes more than 30 accomplished scientific experts and medical and scientific advisory panels. doTERRA remains committed to quality and is responsible for breakthroughs in evolving models of essential oil use, validation of use and state-of-the-art testing procedures.
"doTERRA's mission hinges on discovering and developing the world's most potent and effective essential oils," said Dr. David Hill, doTERRA founding executive and chief medical officer. "These studies are a demonstration of our leadership in essential oil scientific advances, as well as our commitment to ensuring safe and powerful outcomes for families and individuals using doTERRA essential oils."
The newly published papers include studies on:
In addition to doTERRA's expert scientific staff, many of doTERRA's experimental and clinical studies are performed in collaboration with world-class external partner laboratories and clinics carefully chosen according to expertise. doTERRA also supports many clinics and universities conducting studies in the field of essential oils and related natural products research. doTERRA is committed to engaging in ongoing research with a promise of full transparency in its findings.
For more information about doTERRA's research, visit https://doterra.com/US/en/blog/science-research-news.
About doTERRA doTERRA is the world leader in sourcing, testing, manufacturing and distributing CPTG® essential oils through a global network of more than 3 million independent direct-sale distributors, known as Wellness Advocates, and wholesale customers. doTERRA, the Latin derivative meaning "Gift of the Earth," sets the standard for essential oils by providing to its customers the most tested and most trusted oils and having developed the expertise and commitment required to derive these unique oils directly from the best sources in the world. doTERRA Co-Impact Sourcing® provides local growers and distillers fair compensation for their efforts, creating stronger local economies and a healthier, stable supply chain. In addition to a premium line of single-plant extracts and proprietary essential oil blends, the company offers oil-infused personal care and spa products, dietary supplements and healthy living products for the home. For more information, visit www.doterra.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/doterra-publishes-research-on-potency-and-efficacy-of-essential-oils-fulfilling-its-mission-as-most-tested-most-trusted-300496967.html
SOURCE doTERRANEXT ARTICLE
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...